Browse: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | 1 | 3 |
Clark & Elbing LLP patentsThe following is a sampling of recent Clark & Elbing LLP patent applications (USPTO Patent Application #, Patent Title) sorted by month.
July 2009 - Clark & Elbing LLP patents
20090175797 - Inflammation-inhibitory serum factors and uses thereof 20090176743 - Methods for treating or preventing reactivation of a latent herpesvirus infection 20090165876 - Microfluidic structures 20090166562 - Production of microfluidic devices using laser-induced shockwaves 20090169512 - Vaccinia virus strains 20090170767 - Soluble endoglin compounds for the treatment and prevention of cancer 20090170798 - Highly safe intranasally administrable gene vaccines for treating alzheimer's disease June 2009 - Clark & Elbing LLP patents
20090158640 - Process for producing biodiesel with improved filtration characteristics and biodiesel thus produced 20090158640 - Process for producing biodiesel with improved filtration characteristics and biodiesel thus produced 20090162320 - Gene transfer into airway epithelial stem cell by using lentiviral vector pseudotyped with rna virus or dna virus spike protein 20090162320 - Gene transfer into airway epithelial stem cell by using lentiviral vector pseudotyped with rna virus or dna virus spike protein 20090162328 - In vivo assay and molecular markers for testing the phenotypic stability of cell populations and selected cell populations for autologous transplantation 20090162328 - In vivo assay and molecular markers for testing the phenotypic stability of cell populations and selected cell populations for autologous transplantation 20090162943 - Reagents and methods for the detection of transmissible spongiform encephalopathy 20090162943 - Reagents and methods for the detection of transmissible spongiform encephalopathy 20090163451 - Methods for treating visceral pain 20090163451 - Methods for treating visceral pain 20090165154 - Transgenic ungulates having reduced prion protein activity and uses thereof 20090165154 - Transgenic ungulates having reduced prion protein activity and uses thereof 20090155200 - Methods of promoting cartilage healing or cartilage integration 20090155246 - Antibodies specific for soluble amyloid beta peptide protofibrils and uses thereof 20090155386 - Method for treating agricultural products of vegetable origin and the side-products and/or derivatives obtained by treatment 20090156536 - Aimp2-dx2 gene and sirna targeting aimp2-dx2 20090148383 - Anticoagulation agent and uses thereof 20090148425 - Therapeutic method for blood coagulation disorder 20090148860 - Methods of diagnosing muscle damage 20090148896 - Hyperthermophilic dna polymerase and methods of preparation thereof 20090149523 - Use of n-aminoimidazole cytoprotective compounds for treating cell death and/or gsk-3 mediated diseases 20090142335 - Methods of diagnosis and treatment of metabolic disorders 20090142343 - Anti-vegf antibodies 20090143997 - Methods and compositions for cancer treatment relating to brca1 brct domain recognition of phosphorylated bach1 May 2009 - Clark & Elbing LLP patents
20090136420 - Neoplasm-specific polypeptides and their uses 20090137451 - Methods for assessing suitability of cancer patients for treatment with histone deacetylase inhibitors 20090137504 - Microrna target site blocking oligos and uses thereof 20090137532 - Aldolase-inhibiting aromatic compounds 20090130676 - Interaction trap systems for detecting protein interactions 20090130724 - Enzymatic demethylation of flavonoids 20090131361 - Novel use of mln51 gene and protein 20090131414 - Pyrido(3,2-d)pyrimidines and pharmaceutical compositions useful for treating hepatitis c 20090131503 - 3,5 - substituted indole compounds having nos and norepinephrine reuptake inhibitory activity 20090120874 - Membrane for filtering of water 20090123927 - Isolation of precursor cells and their use for tissue repair 20090123976 - Compositions and method for storage of nucleic acid from bodily fluids 20090124664 - (r)-arylalkylamino derivatives and pharmaceutical compositions containing them 20090117185 - 2-(aminomethyl)-5-chlorobenzylamide derivatives and their use as inhibitors of the clotting factor xa 20090117588 - Methods of diagnosing pre-eclampsia or eclampsia 20090117618 - Expression system for preparing il-15/fc fusion protein and its use 20090117652 - Use of cxcl6 chemokine in the prevention or repair of cartilage defects 20090118132 - Classification of acute myeloid leukemia April 2009 - Clark & Elbing LLP patents
20090109518 - Imaging apparatus with a plurality of shutter elements 20090103099 - Integrated surface mode biosensor 20090103099 - Integrated surface mode biosensor 20090103099 - Integrated surface mode biosensor 20090104285 - Methods and compositions for use in treating cancer 20090104285 - Methods and compositions for use in treating cancer 20090104285 - Methods and compositions for use in treating cancer 20090105455 - Purified interleukin-15/fc fusion protein and preparation thereof 20090105455 - Purified interleukin-15/fc fusion protein and preparation thereof 20090105455 - Purified interleukin-15/fc fusion protein and preparation thereof 20090098020 - Binding assay 20090098083 - Conjugate addition reactions for the controlled delivery of pharmaceutically active compounds 20090098105 - Treatment of neurodegenerative diseases by the use of scd4 inhibitors 20090098634 - Scleroprotein of an adeno associated virus with modified chromatographic properties, the production thereof and use of the same 20090098650 - Compositions for the in vitro derivation and culture of embryonic stem (es) cell lines with germline transmission capability and for the culture of adult stem cells 20090099084 - Treatment 20090099242 - Heterocyclic inhibitors of necroptosis 20090092663 - Tumor-targeted drug delivery systems and uses thereof 20090092975 - Selectable marker 20090087449 - Novel peptide compositions and the use thereof, in particular, in the preparation of active pharmaceutical compositions against the hepatitis c virus 20090087449 - Novel peptide compositions and the use thereof, in particular, in the preparation of active pharmaceutical compositions against the hepatitis c virus 20090087859 - Microfluidic device for detecting soluble molecules 20090087859 - Microfluidic device for detecting soluble molecules 20090088343 - Method of patterning and product(s) obtained therefrom 20090088343 - Method of patterning and product(s) obtained therefrom 20090088369 - Glp-1 and methods for treating diabetes 20090088369 - Glp-1 and methods for treating diabetes March 2009 - Clark & Elbing LLP patents
20090081238 - Anti-notch1 nrr antibodies and methods using same 20090082277 - Potentiation of anticancer agents 20090071828 - Devices exhibiting differential resistance to flow and methods of their use 20090075879 - Novel peptide compositions and the use thereof, in particular, in the preparation of active pharmaceutical compositions against the hepatitis c virus 20090075911 - Ester derivatives of hyaluronic acid for the preparation of hydrogel materials by photocuring 20090075951 - Methods and reagents for the treatment of inflammatory disorders 20090075955 - Therapeutic regimens for the treatment of immunoinflammatory disorders 20090076257 - Ester derivatives of hyaluronic acid for the preparation of hydrogel materials by photocuring 20090077681 - Methods for diagnosing and treating heart disease 20090068156 - Treatment of muscular dystrophy with cord blood cells 20090068247 - Biocompatible devices coated with a tribonectin and methods for their production 20090068645 - Labeling and sequencing of nucleic acids 20090060969 - Porous biodegradable polymeric materials for cell transplantation 20090062198 - Maurotoxin, pi1 and hstx1 derivatives February 2009 - Clark & Elbing LLP patents
20090053168 - Treatments of b-cell proliferative disorders 20090053254 - Recombinant human alpha-fetoprotein as an immunosuppressive agent 20090053718 - Novel oligonucleotide compositions and probe sequences useful for detection and analysis of micrornas and their target mrnas 20090053738 - Protease detection 20090054370 - Pyrimidines, such as uridine, in treatments for patients with bipolar disorder 20090054410 - Thiadiazole derivatives for the treatment of neurodegenerative diseases 20090047243 - Combinations for the treatment of b-cell proliferative disorders 20090047738 - Feeder cell derived from tissue stem cell 20090048161 - Cytokine receptor modulators and uses thereof 20090048177 - Methods for the treatment of mood disorders 20090041626 - Instrumentation systems and methods 20090041778 - Methods and compositions for the treatment of graft failure 20090041852 - Dry powder compositions and systems for poultry vaccination 20090042793 - Novel antiviral therapies 20090042814 - Treatment and diagnosis of obligate intracellular pathogens 20090035428 - Process and device for desolventising under reduced pressure 20090035799 - Novel trypsin family serine proteases 20090036382 - Tgf-beta modulators and use thereof 20090036430 - Pyrido(3,2-d)pyrimidines and pharmaceutical compositions useful for medical treatment January 2009 - Clark & Elbing LLP patents
20090027142 - Multi-band transducer for multi-band feed horn 20090029409 - Method for determination of oxidative stress 20090029460 - Neoplasm-specific polypeptides and their uses 20090029999 - Synephrine derivatives useful as anti-inflammatory agents 20090023149 - Methods, kits and devices for identifying biomarkers of treatment response and use thereof to predict treatment efficacy 20090023221 - Oligonucleotide probes useful for detection and analysis of microrna precursors 20090023594 - Reagents for labelling nucleic acids and uses thereof 20090023666 - Modulators of hypoxia inducible factor-1 and related uses 20090016959 - Delivery of antibodies to the central nervous system 20090019602 - Master activators of pathogen responsive genes 20090007555 - Biomimetic water membrane comprising aquaporins used in the production of salinity power 20090010927 - Mapkap kinase-2 as a specific target for blocking proliferation of p53-defective cells 20090010934 - Cell lines, ligands and antibody fragments for use in pharmaceutical compositions for preventing and treating haemostasis disorders 20090010996 - Human antibiotic proteins 20090011979 - Immunomodulatory protein and useful embodiments thereof 20090011981 - Novel inhibitors of angiogenesis 20090004669 - Methods of diagnosing pre-eclampsia or eclampsia 20090005346 - Azacytosine derivatives useful as antiviral agents 20090005358 - Compositions and methods for treating medical conditions 20090005648 - Method for the diagnosis of attention-deficit/hyperactivity disorder October 2008 - Clark & Elbing LLP patents
20080260736 - Methods and compositions to regulate iron metabolism 20080262160 - Monodisperse polymers containing (alkyl)acrylic acid moieties, precursors and methods for making them and their applications 20080254069 - Vaccines for immunization against helicobacter 20080248033 - Vegf-specific antagonists for adjuvant and neoadjuvant therapy and the treatment of early stage tumors 20080248552 - Method of cell cultures and device for implementing it 20080249302 - Substituted indole compounds having nos inhibitory activity 20080241906 - Scleroprotein of an adeno-associated virus with modified chromatographic properties, the production thereof and use of the same 20080242646 - Split dose corticosteroid therapy September 2008 - Clark & Elbing LLP patents
20080234237 - Quinolone and tetrahydroquinolone and related compounds having nos inhibitory activity 20080234467 - Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis 20080226547 - Alpha-emitting hydroxyapatite particles 20080226565 - Anticariogenic proteins & peptides & saccharides 20080226594 - Culturing circular ssdna viruses for the production of vaccines 20080226720 - Wound healing composition 20080227745 - Methods and compositions for soluble cpg15 20080227848 - Assays 20080227954 - Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis 20080228253 - Surface modifying macromolecules with high degradation temperatures and uses thereof 20080220292 - Microbial fuel cells for oxidation of electron donors 20080220423 - Oligonucleotide probes useful for detection and analysis of microrna precursors 20080220473 - Endo-n-acetyl-beta-d-glucosaminidase enzymes of filamentous fungi 20080221076 - Crystalline sodium salt of cephalosporin antibiotic 20080213250 - Use of eph receptor inhibitors for the treatment of neurodegenerative diseases 20080213454 - Genetic transformation of apple without use of a selectable marker 20080213777 - Tumor suppressor pathway in c. elegans 20080214613 - Substituted benzimidazole compounds with dual nos inhibitory activity and mu opioid agonist activity 20080214802 - Substituted liposaccharides useful in the treatment and prevention of endotoxemia August 2008 - Clark & Elbing LLP patents
20080206254 - Novel anti-factor viii antibodies 20080208268 - Means for functional restoration of a damaged nervous system 20080199426 - Methods and compositions for the treatment and diagnosis of vascular inflammatory disorders or endothelial cell disorders 20080199438 - Methods for suppressing tumor proliferation 20080199440 - Tissue repair using allogenic dermal fibroblasts 20080199449 - Methods and compositions for use in treating vascular diseases and conditions 20080193329 - Method and system for plasma treatment under high pressure 20080193374 - Liposomes enclosing a radionuclide and a cytotoxic agent for combination therapy 20080193455 - Novel anti-plgf a antibody 20080193477 - Vaccination against dengue virus infection 20080193485 - Food containing a probiotic and an isolated beta-glucan and methods of use thereof 20080193507 - Wound healing profile 20080194029 - Method for increasing the ratio of homologous to non-homologous recombination 20080194421 - Screening system for identifying drug-drug interactions and methods of use thereof 20080195349 - Calorimetric measuring device 20080188516 - Imiadazo[4,5-c] pyridine compound and method of antiviral treatment 20080188946 - Osteoinductive bone material July 2008 - Clark & Elbing LLP patents
20080181886 - Polypeptides that bind baff and/or april 20080181888 - Polypeptides that bind br3 and uses thereof 20080182870 - Pyrido(3,2-d)pyrimidines useful for treating viral infections 20080183156 - Closed suction drainage apparatus with drainage tube having anti-clogging and irrigating functions 20080175862 - Recombinant flavivirus vaccines 20080176027 - Half closed thermoplastic honeycomb, their production process and equipment to produce 20080171036 - Taci antibodies and uses thereof 20080167230 - Methods and compositions for treating or preventing lesions of the respiratory epithelium 20080159899 - Process for producing sintered porous materials 20080160537 - Particle based binding assay 20080161193 - Differential phage capture proteomics 20080161199 - Fusion proteins and methods for determining protein-protein-interactions in living cells and cell lysates, nucleic acids encoding these fusion proteins, as well as vectors and kits containing these 20080161324 - Compositions and methods for treatment of viral diseases June 2008 - Clark & Elbing LLP patents
20080152673 - Desiccated product 20080153128 - Cell-free protein synthesis 20080145860 - Encapsulated cell indicator system 20080146811 - Compounds and methods for treatment of thrombosis 20080138330 - Methods and compositions for treating conditions involving abnormal angiogenesis 20080138342 - Methods of treating pre-eclampsia and eclampsia 20080139458 - Methods of treatment for injured or diseased joints 20080139492 - Compositions and methods that enhance rna interference 20080139785 - Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis 20080131409 - Methods and compositions for the treatment of medical disorders 20080132472 - Compounds for the treatment of psychiatric or substance abuse disorders May 2008 - Clark & Elbing LLP patents
20080121494 - Mobile gastronomic table for serving out food 20080125388 - Methods and compositions for cpg15-2 20080102026 - Hypoxia-selective, weakly basic 2-nitroimidazole delivery agents and methods of use thereof 20080102054 - Compositions containing agm cells and methods of use thereof 20080102162 - Prebiotic preparation 20080102504 - Methods and apparatus for characterizing polynucleotides April 2008 - Clark & Elbing LLP patents
20080095786 - Compositions and methods for preventing and treating endotoxin-related diseases and conditions 20080095803 - Protein matrix vaccines and methods of making and administering such vaccines 20080096841 - Treatment and prevention of heat shock protein-associated diseases and conditions 20080085237 - Weakly basic 2-nitroimidazoles for the non-invasive detection of tissue hypoxia 20080085835 - Rps gene family, primers, probes and detection methods 20080081097 - Phase transfer apparatus and process 20080081338 - Diagnostic method March 2008 - Clark & Elbing LLP patents
20080075792 - Method for inhibiting the activity of dpp-iv and lowering blood glucose level 20080076674 - Novel oligonucleotide compositions and probe sequences useful for detection and analysis of non coding rnas associated with cancer 20080069820 - Multispecific antibodies 20080070293 - Enzyme-based monitoring device for thermal processing of objects 20080064038 - Autism genes and regulated secretion 20080064081 - Structural protein of adeno-associated virus with modified antigenicity, its production and its use 20080064648 - Methods and compositions relating to lipid accumulation 20080064652 - Methods and compositions for treating hypercholesterolemia 20080064965 - Devices and methods for measuring pulsus paradoxus 20080058429 - Diagnosis of primary open angle glaucoma February 2008 - Clark & Elbing LLP patents
20080051599 - Production of esters of fatty acids and lower alcohols 20080040941 - Measurement configuration based on linear scales able to measure to a target also moving perpendicular to the measurement axis 20080044390 - Methods and compositions for the treatment of neurodegenerative disorders 20080038234 - Bone marrow-related cells associated with tissue maintenance and/or repair 20080038249 - Treatment of neurodegenerative diseases by the use of laptm4a 20080039911 - Adhesion prevention and an intra-luminal cooling system therefor 20080040821 - Transgenic ungulates capable of human antibody production 20080028992 - Delayed-setting calcium phosphate pastes 20080031850 - Tissue regeneration method 20080031819 - Compositions and methods that enhance articular cartilage repair 20080031822 - Methods of modeling migraine pain and identifying candidate compounds for the treatment of migraine 20080031855 - Anticancer agent containing minus-strand rna virus 20080032955 - Vitamin d3 analogues for the prevention and treatment of bone disorders January 2008 - Clark & Elbing LLP patents
20080025929 - Topical formulations for the treatment of skin conditions 20080025965 - Methods and compositions for the treatment of diseases or conditions associated with increased c-reactive protein levels 20080025969 - Treatment of neurodegenerative diseases by the use of gpr49 20080026003 - Methods for inhibiting pain 20080020991 - Methods of treating, reducing, or preventing autoimmune conditions 20080021351 - Method for diagnosing adhd and related behavioral disorders 20080021564 - Humeral head resurfacing implant and methods of use thereof 20080014183 - Anticancer agent containing dendritic cell having rna virus transferred thereinto 20080015152 - Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis 20080009010 - Methods for diagnosis and prognosis of psychotic disorders 20080009487 - Treatment of athersclerotic disease 20080003213 - Methods and compositions for the treatment of diseases or conditions associated with increased c-reactive protein, interleukin-6, or interferon-gamma levels 20080003256 - Biocompatible coating of medical devices 20080004285 - Pyrido(3,2-d)pyrimidines and pharmaceutical compositions useful for medical treatment December 2007 - Clark & Elbing LLP patents
20070298015 - Treatment of muscular dystrophy with mobilized peripheral blood pluripotent cells 20070298029 - Treatment of neurodegenerative diseases by the use of degs inhibitors 20070298051 - Adjuvants of immune response 20070299010 - Cpg15 and cpg15-2 compounds and inhibitors as insulin receptor and insulin-like growth factor receptor agonists and antagonists 20070299043 - Anti-scarring drug combinations and use thereof 20070292426 - Methods and compositions based on shiga toxin type 1 protein 20070292851 - Methods for identifying candidate compounds for treating, reducing, or preventing pathogenic infections 20070293418 - Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis 20070280927 - Treatment of neurodegenerative diseases by the use of atp7a 20070281329 - Characterization of individual polymer molecules based on monomer-interface interactions November 2007 - Clark & Elbing LLP patents
20070274971 - Method of proliferating precursor cells 20070274991 - Treatment of tumors expressing mutant egf receptors 20070275015 - West nile virus vaccine 20070275068 - Controlled release delivery system for bio-active agents 20070275071 - Use of microparticles for antigen delivery 20070275380 - Method for distinguishing aml subtypes with aberrant and prognostically intermediate karyotypes 20070275416 - Affinity marker for purification of proteins 20070275900 - Prodrugs cleavable by cd26 20070269414 - Method for producing gene transferred denritic cells 20070269425 - Anti-idiotype antibodies of the human monoclonal antibody sc-1, and their production and use 20070269434 - Tat-041 and methods of assessing and treating cancer 20070269458 - Vaccines against japanese encephalitis virus and west nile virus 20070269539 - Ginkgo biloba extract as a treatment for therapeutic-induced neurotoxicity 20070269830 - Process for the identification of new medical targets 20070264244 - Pigment epithelial cell of the eye, its production and use in therapy of an eye or cns disease 20070264276 - Vaccine for the prevention and treatment of alzheimer's and amyloid related diseases 20070264306 - Scaffold engineering 20070264675 - Microfluidic device for cell separation and uses thereof 20070259358 - Integrase cofactor 20070259424 - Microfluidic device for cell separation and uses thereof 20070259816 - Drg11-responsive axonal guidance and outgrowth of neurite (dragon) gene family 20070259831 - Treatment and screening methods for promoting neurogenesis 20070259841 - Combinations for the treatment of rheumatoid arthritis 20070253939 - Cell delivery system 20070254002 - Biocompatible devices coated with activated protein c 20070254063 - Use of hop polyphenols in beer 20070254288 - Diagnostic methods for pain sensitivity and chronicity and for tetrahydrobiopterin-related disorders 20070254940 - 1,5 and 3,6- substituted indole compounds having nos inhibitory activity 20070255254 - Cell delivery system October 2007 - Clark & Elbing LLP patents
20070248574 - Methods of making and using skin-derived stem cells 20070248627 - Gene therapy for tumors using minus-strand rna viral vectors encoding immunostimulatory cytokines 20070248668 - Pharmaceutical compositions and uses thereof 20070249557 - Compositions and methods for viscosupplementation 20070244148 - Imidazo 4,5-c pyridine compounds and methods of antiviral treatment 20070244187 - Intermediates for the preparation of halichondrin b 20070238670 - Novel compositions and methods for promoting, inhibiting and detecting protein entry into cells 20070238684 - Aav scleroprotein, production and use thereof 20070238747 - Rifamycin analogs and uses thereof 20070231308 - Glucagon-like-peptide-2 (glp-2) analogues 20070231336 - Immunization against clostridium difficile disease 20070231851 - Microfluidic device for cell separation and uses thereof 20070231863 - Drg11-responsive axonal guidance and outgrowth of neurite (dragon) gene family September 2007 - Clark & Elbing LLP patents
20070225217 - Methods, compositions, and kits for the treatment of medical conditions 20070219277 - Small molecules used to increase cell death 20070220620 - Tat-046 and methods of assessing and treating cancer 20070212733 - Methods and compositions related to b cell assays 20070212747 - Cassette containing growth medium 20070213296 - Compositions and methods for the treatment of immunoinflammatory disorders 20070213308 - Methods, compositions, and kits for the treatment of musculoskeletal disorders and symptoms associated therewith 20070213394 - Salvinorin derivatives and uses thereof 20070213964 - Method and device for predicting risk of decompression sickness 20070208134 - Anti-scarring drug combinations and use thereof August 2007 - Clark & Elbing LLP patents
20070202546 - Immunoassay carrier 20070196418 - Drug delivery methods and devices 20070196421 - Soft tissue implants and drug combination compositions, and use thereof 20070196820 - Devices and methods for enrichment and alteration of cells and other particles 20070196878 - Immune diagnostic assay to diagnose and monitor tuberculosis infection 20070196917 - Methods of constructing a gene mutation library and compounds and compositions thereof 20070197957 - Implantable sensors, implantable pumps and anti-scarring drug combinations 20070198063 - Electrical devices and anti-scarring drug combinations 20070189942 - Sterilizer for medical devices 20070190575 - Osteoactivin protein and nucleic acids encoding the same, compositions and methods of stimulating bone differentiation 20070192883 - Tat-028 and methods of assessing and treating cancer 20070192884 - Tat-038 and methods of assessing and treating cancer 20070192885 - Tat-039 and methods of assessing and treating cancer 20070192886 - Tat-044 and methods of assessing and treating cancer 20070192887 - Tat-042 and methods of assessing and treating cancer 20070181462 - A process for the production of needle coke 20070184052 - Soluble tgf-b type iii receptor fusion proteins 20070184544 - Culturing circular ssdna viruses for the production of vaccines 20070185018 - Use of secretin in treatments of disorders associated with the amygdala 20070185062 - Phosponate nucleosides useful as active ingredients in pharmaceutical compositions for the treatment of viral infections, and intermediates for their production 20070185343 - Metal complexes for use in olefin metathesis and atom group transfer reactions 20070186288 - Zebrafish models of acute myelogenous leukemia 20070186294 - Tat-030 and methods of assessing and treating cancer 20070186295 - Tat-036 and methods of assessing and treating cancer 20070175829 - Pressure driven separation of liquid feeds 20070179152 - Combination therapy for the treatment of neoplasms 20070179455 - Needle constructed with a transparent or translucent material 20070180545 - Tat-031 and methods of assessing and treating cancer July 2007 - Clark & Elbing LLP patents
20070171225 - Time-dependent three-dimensional musculo-skeletal modeling based on dynamic surface measurements of bodies 20070172824 - Method for amplifying unknown dna sequence adjacent to known sequence 20070172853 - Use of deletion polymorphisms to predict, prevent, and manage histoincompatibility 20070172903 - Microfluidic device for cell separation and uses thereof 20070173466 - Methods of treating inflammatory diseases associated with bone destruction 20070173489 - Inhibitors of the gpib-vwf interaction, their preparation and use 20070166286 - Self-rearranging dna vectors 20070166702 - Methods for predicting the efficacy or outcome of hcv therapy 20070167409 - Compounds and methods for treating toll-like receptor 2-related diseases and conditions 20070169211 - Non-glycosylated human alpha-fetoprotein, methods of production, and uses thereof 20070160503 - Microfluidic systems for size based removal of red blood cells and platelets from blood 20070160600 - Compositions and methods of monoclonal and polyclonal antibodies specific for t cell subpopulations 20070160607 - Humanized monoclonal antibodies that protect against shiga toxin induced disease 20070160953 - Method for manufacturing a prosthesis made prior to implant placement 20070161005 - Culturing circular ssdna viruses for the production of vaccines 20070161050 - Monoclonal antibodies to mesenchymal stem cells 20070161110 - Methods for producing minus-strand rna viral vectors using hybrid promoter comprising cytomegalovirus enhancer and chicken beta-actin promoter 20070153652 - Recording and/or reproducing methods and apparatuses 20070153653 - Recording and/or reproducing methods and appratuses 20070154482 - Methods and compositions for the treatment and diagnosis of diseases characterized by vascular leak, hypotension, or a procoagulant state 20070154904 - Methods for identifying novel nucleic acid regulatory elements and compounds that affect the regulation 20070155715 - Rifamycin analogs and uses thereof June 2007 - Clark & Elbing LLP patents
20070148733 - Yeast expression vectors for production of itf 20070149469 - Medical use of tbk-1 or of inhibitors thereof 20070141634 - Assay 20070141705 - Method for producing viral vectors 20070142392 - Uses of rifamycins 20070135337 - Vaccine for the prevention and treatment of alzheimer's and amyloid related diseases 20070128173 - Use of polysulphated alginate in cellular matrices 20070128245 - Porous calcium phosphate bone material 20070128591 - Methods for diagnosing and treating diseases and conditions of the digestive system and cancer May 2007 - Clark & Elbing LLP patents
20070122340 - Necrosis avid tracer agent 20070122814 - Methods for distinguishing prognostically definable aml 20070123469 - N- or c- terminally modified small peptides 20070116688 - Methods of organ regeneration 20070117144 - Oligonucleotides useful for detecting and analyzing nucleic acids of interest 20070117163 - Anti-aurora-a monoclonal antibody, method for obtaining same and uses thereof for diagnosing and treating cancers 20070117752 - Glucagon-like-peptide-2 (glp-2) analogues 20070117836 - Napthalimide derivatives, methods for their production and pharmaceutical compositions therefrom 20070110685 - Combination therapy for the treatment of immunoinflammatory disorders 20070110819 - Composite structures containing hyaluronic acid the derivatives thereof as new bone substitutes and grafts 20070111327 - Methods of detecting lubricin 20070111940 - Peptide agonists of glp-1 activity 20070112018 - Treatment of peripheral arterial occlusive disease 20070104699 - Compositions for and methods of granzyme b inhibition 20070104707 - Methods of diagnosing and treating complications of pregnancy 20070105167 - Virulence associated nucleic acid sequences and uses thereof 20070105208 - Minus strand rna virus vector carrying gene modified in high mutation region 20070105761 - Methods, compositions, and kits for the treatment of opthalmic disorders 20070105849 - Rifamycin analogs and uses thereof 20070106065 - Tat- 001 and methods of assessing and treating cancer 20070099196 - Novel oligonucleotide compositions and probe sequences useful for detection and analysis of micrornas and their target mrnas 20070099201 - Methods for detecting and quantifying binding and inhibition of binding of species to nucleic acids 20070099207 - Devices and methods for enrichment and alteration of circulating tumor cells and other particles 20070099289 - Device and method for contacting picoliter volumes of fluid 20070099905 - Combinations of drugs for the treatment of neoplasms 20070099906 - Combinations for the treatment of noeplastic disorders April 2007 - Clark & Elbing LLP patents
20070087378 - Polynucleotide and polypeptide fat metabolism regulators and uses thereof 20070088248 - Devices for transcutaneous delivery of vaccines and transdermal delivery of drugs and uses thereof 20070081999 - Antithrombotic von willebrand factor (vwf) collagen bridging blockers 20070082054 - Particle size reduction of bioactive compounds 20070082840 - Combination therapy for inhibition of platelet aggregation 20070078185 - Methods and compositions for controlling invertebrate pests February 2007 - Clark & Elbing LLP patents
20070043000 - Immunosuppresive effects of pteridine derivatives 20070043002 - Aldolase-inhibiting aromatic compounds 20070043188 - Multicoordinated metal complexes for use in metathesis reactions 20070044167 - Method for producing avian chimera using spermatogonial cells and avian chimera 20070036756 - Method for treating ischemic diseases 20070037210 - Cytokine receptor modulators, method of identifying same, and method of modulating cytokine receptors activity with same 20070037891 - Methods and compositions for the delivery of biologically active agents 20070031438 - Antibodies as chimeric effector cell receptors against tumor antigens 20070032477 - Pteridine derivatives useful for making pharmaceutical compositions 20070025914 - Bronchioalveolar stem cells and uses thereof 20070026381 - Devices and methods for enrichment and alteration of cells and other particles 20070026413 - Devices and methods for enrichment and alteration of circulating tumor cells and other particles 20070026414 - Devices and methods for enrichment and alteration of circulating tumor cells and other particles 20070026415 - Devices and methods for enrichment and alteration of circulating tumor cells and other particles 20070026416 - Devices and methods for enrichment and alteration of circulating tumor cells and other particles 20070026417 - Devices and methods for enrichment and alteration of circulating tumor cells and other particles 20070026418 - Devices and methods for enrichment and alteration of circulating tumor cells and other particles 20070026419 - Devices and methods for enrichment and alteration of circulating tumor cells and other particles 20070026469 - Devices and methods for enrichment and alteration of circulating tumor cells and other particles 20070027103 - Methods and compositions for silencing genes without inducing toxicity 20070027127 - Treatment of inflammatory oral diseases with a combination of inhibitors of tnf-alpha and immunosuppressive agents January 2007 - Clark & Elbing LLP patents
20070020285 - Novel peptide compositions and the use thereof, in particular, in the preparation of active pharmaceutical compositions against the hepatitis c virus 20070015246 - Novel prostate-specific or testis-specific nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods 20070015718 - Diagnosis and management of infection caused by chlamydia 20070009592 - Immediate release pharmaceutical granule compositions and a continuous process for making them 20070009949 - Paramyxovirus-derived rnp 20070010502 - Methods and reagents for the treatment of immunoinflammatory disorders 20070010541 - Methods for treating vascular diseases 20070003560 - Humanized monoclonal antibodies that protect against shiga toxin induced disease 20070004623 - Use of hydroxylated amino acids for treating diabetes 20070004721 - Pteridine derivatives for the treatment of septic shock and tnf-a-related diseases 20070004905 - Solid-phase peptide synthesis and agent for use in such synthesis 20070005139 - Tissue engineered tendons and ligaments December 2006 - Clark & Elbing LLP patents
20060292149 - Variable antibodies 20060292179 - Vaccines for immunization against helicobacter 20060294603 - Cloning of transgenic animals comprising artificial chromosomes 20060283686 - Mobile gastronomic table for serving out food 20060286125 - Nucleic acid molecules and polypeptides for immune modulation 20060286167 - Compositions and methods for the treatment of neurodegenerative diseases 20060286177 - Methods and reagents for the treatment of inflammatory disorders 20060287314 - Immunosuppressive effects of pteridine derivatives 20060287503 - Retinoid x receptor-interacting polypeptides and related molecules and methods 20060280798 - Nanoparticles for delivery of a pharmacologically active agent 20060281046 - Stent for guiding the location/direction of implant, and production method thereof 20060281722 - Compounds and uses thereof 20060275748 - Integrase cofactor 20060276562 - Composite materials for bone defect filling and bone replacement November 2006 - Clark & Elbing LLP patents
20060269520 - Xiap therapy 20060269944 - Mass intensity profiling system and uses thereof 20060269945 - Constellation mapping and uses thereof 20060270742 - Compositions and methods for the treatment of neurodegenerative diseases 20060263366 - Neoplasm specific antibodies and uses thereof 20060263859 - Method for preparing 3'-amino-2',3'-dideoxyguanosine 20060263876 - Neural crest stem cells and uses thereof 20060264384 - Compositions and methods for treatment for neoplasms 20060257381 - Method for transplanting lymphohematopoietic cells into mammal 20060257660 - Antistatic agent for vinyl chloride-based resins, vinyl chloride-based resin composition containing the same, and method for manufacturing this composition 20060257901 - Methods of diagnosing fetal trisomy 13 or a risk of fetal trisomy 13 during pregnancy 20060258721 - Substituted indole compounds having nos inhibitory activity 20060253014 - Methods for identifying anatomical and molecular targets for analgesic therapy 20060246031 - Use of cxcl6 chemokine in the prevention or repair cartilage defects 20060246046 - Modified tridegins, production and use thereof as transglutaminase inihibitors October 2006 - Clark & Elbing LLP patents
20060239985 - Method of preparing cell for transplantation 20060239998 - Anti-idiotypic antibodies against factor viii inhibitor and uses thereof 20060240014 - Methods and compounds for the treatment of vascular stenosis 20060240037 - Methods and compositions for the treatment and prevention of degenerative joint disorders 20060240121 - Chemotherapeutic composition using nanocrystalline calcium phosphate paste 20060241122 - Combination therapy for the treatment of neoplasms 20060234991 - Combinations for the treatment of immunoinflammatory disorders 20060235001 - Compositions for the treatment of neoplasms 20060236411 - Antagonists il-15 20060228297 - Thorium-227 for use in radiotherapy of soft tissue disease 20060222655 - Compositions and methods for preventing and treating endotoxin-related diseases and conditions 20060223178 - Devices and methods for magnetic enrichment of cells and other particles 20060223733 - Compositions and methods for use in unclogging drains and pipes 20060223884 - Compounds and compositions for use in the prevention and treatment of obesity and related syndromes September 2006 - Clark & Elbing LLP patents
20060216227 - Catalysts for hydrogen production 20060216824 - Paramyxovirus vector encoding ribozyme and utilization thereof 20060217344 - Compounds for the treatment of tobacco dependence and withdrawal 20060218657 - Method for improving germline transmission efficiency of avian primordial germ cells 20060211608 - Use of a parathyroid hormone peptide analogs for the treatment of viginal atrophy 20060212952 - Methods for cloning mammals using reprogrammed donor chromatin or donor cells 20060201504 - High-flow oxygen delivery system and methods of use thereof 20060204921 - Dental articulator having dual balls 20060205764 - Inhibition of platelet aggregation 20060199771 - Stereoselective antifibrillogenic peptides and peptidomimetics thereof 20060199853 - Analogs of 4-hydroxyisoleucine and uses thereof 20060200873 - Salicylic acid biosynthetic genes and uses thereof
###
This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Clark & Elbing LLP in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Clark & Elbing LLP with additional patents listed. Browse our Agent directory for other possible listings.
###
FreshPatents.com Support
|